Cargando…
Efficacy and Safety of Direct Oral Anticoagulants for Atrial Fibrillation Across Body Mass Index Categories
BACKGROUND: Direct‐acting oral anticoagulants are now the preferred method of anticoagulation in patients with atrial fibrillation. Limited data on efficacy and safety of these fixed‐dose regimens are available in severe obesity where drug pharmacokinetics and pharmacodynamics may be altered. The ob...
Autores principales: | Kaplan, Rachel M., Tanaka, Yoshihiro, Passman, Rod S., Fine, Michelle, Rasmussen‐Torvik, Laura J., Vupputuri, Suma, Martin, Karlyn, Khan, Sadiya S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955357/ https://www.ncbi.nlm.nih.gov/pubmed/33302751 http://dx.doi.org/10.1161/JAHA.120.017383 |
Ejemplares similares
-
Trends in Cardiovascular Mortality Related to Atrial Fibrillation in the United States, 2011 to 2018
por: Tanaka, Yoshihiro, et al.
Publicado: (2021) -
Racial Disparity in Referral for Catheter Ablation for Atrial Fibrillation at a Single Integrated Health System
por: Duke, Jessica M., et al.
Publicado: (2022) -
Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation
por: Kaplan, Rachel M., et al.
Publicado: (2020) -
Monitoring for AF: Identifying the Burden of Atrial Fibrillation and Assessing Post-Ablation
por: Passman, Rod S.
Publicado: (2017) -
Rivaroxaban Monotherapy in Atrial Fibrillation and Stable Coronary Artery Disease Across Body Mass Index Categories
por: Ishii, Masanobu, et al.
Publicado: (2022)